Product Description : LOXO-292 is a selective and potent RET inhibitor and an investigational drug in clinical development for the treatment of patients with cancers that harbor abnormalities in the rearranged during transfection (RET) kinase.
CAS Number : 2222755-14-6
Molecular Weight : 553.61
Format : C29H31N9O3
Purity : ?98%
All prices shown are exclusive of VAT